Cargando…

HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B

BACKGROUND: A recent genome-wide association study has identified a new susceptibility locus, kinesin family member 1B gene (KIF1B), strongly associated with progression from chronic hepatitis B (CHB) to hepatitis B virus-related hepatocellular carcinoma (HCC) in Chinese population, this study was c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Rong, Tian, Yao, Liu, Li, Qiu, Qian, Wang, Ying, Rui, Rui, Yang, Bei-Fang, Duan, Sheng-Yu, Shi, Jun-Xin, Miao, Xiao-Ping, Wang, Li, Li, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283615/ https://www.ncbi.nlm.nih.gov/pubmed/22363396 http://dx.doi.org/10.1371/journal.pone.0028839

Ejemplares similares

Role of Single Nucleotide Polymorphisms of KIF1B Gene in HBV-Associated Viral Hepatitis
por: Al-Qahtani, Ahmed, et al.
Publicado: (2012)

Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma
por: Li, Cong, et al.
Publicado: (2014)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis
por: Zhang, Ya-fei, et al.
Publicado: (2018)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation
por: Huang, Xiaodong, et al.
Publicado: (2013)

Association between KIF1B rs17401966 genetic polymorphism and hepatocellular carcinoma susceptibility: an updated meta-analysis
por: Luo, Ying-ying, et al.
Publicado: (2019)

Evolution of Hepatitis B Virus in a Chronic HBV-Infected Patient over 2 Years
por: Shen, Tao, et al.
Publicado: (2011)

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma
por: Petruzziello, Arnolfo
Publicado: (2018)

Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma
por: Wang, Zhi-Chao, et al.
Publicado: (2013)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
por: Sartorius, Kurt, et al.
Publicado: (2019)

Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma
por: Bousali, Maria, et al.
Publicado: (2022)

DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites
por: Wu, Canbiao, et al.
Publicado: (2021)

Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy
por: Rui, Shaozhen, et al.
Publicado: (2017)

Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk
por: Jing, Ying-Ying, et al.
Publicado: (2015)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Analysis of Kif5b Expression during Mouse Kidney Development
por: Cui, Ju, et al.
Publicado: (2015)

Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma
por: Qu, Chao, et al.
Publicado: (2019)

Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma
por: Yin, Jia Wen, et al.
Publicado: (2016)

Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma
por: Mani, Saravana Kumar Kailasam, et al.
Publicado: (2020)

Evaluation of Genetic Susceptibility Loci for Chronic Hepatitis B in Chinese: Two Independent Case-Control Studies
por: Wang, Li, et al.
Publicado: (2011)

Dexamethasone Stimulates Hepatitis B Virus (HBV) Replication Through Autophagy
por: He, Qiao, et al.
Publicado: (2018)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
por: Sun, Yeping, et al.
Publicado: (2018)

The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
por: Sartorius, Kurt, et al.
Publicado: (2020)

Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
por: Vanwolleghem, Thomas, et al.
Publicado: (2021)

Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
por: Zhao, Hui-Qi, et al.
Publicado: (2020)

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2017)

Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide
por: Marcelino, Rute, et al.
Publicado: (2022)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

Circular RNA circ_0032462 Enhances Osteosarcoma Cell Progression by Promoting KIF3B Expression
por: Gu, Rui, et al.
Publicado: (2020)

Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
por: Li, Yan, et al.
Publicado: (2022)

Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
por: Zhou, Zhong-Guo, et al.
Publicado: (2015)

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection
por: Zhang, Hong, et al.
Publicado: (2020)

Association of CD44 polymorphisms and susceptibility to HBV‐related hepatocellular carcinoma in the Chinese population
por: Deng, Yan, et al.
Publicado: (2019)

Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B
por: Li, Lei, et al.
Publicado: (2013)

Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis
por: Zhang, Qi, et al.
Publicado: (2011)

Relationship Between HBV Genotypes B, C and Follicular Helper T Cells in Patients with Chronic Hepatitis B and its Significance
por: Xibing, Gu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f3osmipfir7g5mv3ngr8v661vp